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Chest pain is the second most common reason Americans visit 
the emergency room, which amounts to 7-8 million visits each 
year [1]. These visits are often because when chest pain 
ensues, the first thing people think is heart attack. However, 
several factors can cause chest pain, such as stress and 
panic attacks. 
A heart attack, or myocardial infarction, occurs when blood flow 
to the heart is restricted, often by a blood clot (Figure 1).  
Before the onset of a heart attack, myocardial ischemia, which 
is an inadequate blood supply to the heart, can occur. 
  
 
 
 
 
 
 
 
 
 
 
Problem 
Current tests for myocardial infarction use the biomarker, 
troponin, for diagnosis. Diagnostic levels of troponin are 
observed hours after the event. 
 
Diagnosis of infarction via troponin: 
1.  Prolonged myocardial ischemia 
2.  Myocardial infarction 
3.  Ambulance to ER 
4.  Treatment (hours wait for troponin test) 
5.  Confirmed diagnosis 
6.  Further treatment 
 
There is a critical need for detection methods that yield much 
sooner diagnoses of infarction or rather possibilities of infarction. 
New Assay: 
•  A VCU patented chemiluminescent assay [2] uses xanthine oxidase (XO) 
activity in a microliter sample of blood to detect biomarkers inosine and 
hypoxanthine indicative of myocardial ischemia (Figure 2). Prolonged and 
untreated ischemia leads to infarction. 
•  Metabolic byproducts of XO activity is detectable within minutes of an 
ischemic event. 
 
 
 
 
 
 
 
 
Objective: 
•  To build a point-of-care device to screen for cardiac ischemia using the 
VCU patented assay. 
 
Design Criteria: 
•  Rapid (less than 10 minutes) analysis time  
•  Sensitive (20µL plasma sample) and specific to inosine and hypoxanthine 
•  Portable (handheld) device 
 
Design Approach: 
•  The device will contain a multilayered microfluidic lab-on-chip (Figure 3) 
where the assay will be run. 
 
 
 
 
 
 
 
 
•  Plasma and assay reagents enter the device through circular inlet ports.  
Solutions mix within micromixing channels (pleated arrow pattern). 
Reaction products feed into an Archimedean spiral which amplifies the 
chemiluminescent signal for detection using a luminometer [3]. 
 
Luminescence: 
Comparing results from a single  
well in 12 well plate (SA = 4 cm2)  
to the spiral on chip (SA = 6 cm2),  
a 5 fold increase, as shown in 
Figure 4, in luminescence 
intensity was measured from 0.2 mL 
of luminol at a concentration of  
24 mg/mL. 
 
 
Future Improvements 
 
•  Installing a system to separate plasma from whole blood. 
•  Installing a system to include prepared reagents. 
•  Optimizing channels for better mixing and incubation times. 
•  Reverse engineering a portable luminometer to detect 
chemiluminescence on the LOC. 
•  Installing a digital display to output YES or NO result. 
Potential users: 
•  Hospital/clinic personnel  
•  Emergency Medical Services (EMS) personnel 
•  Patients testing at home 
 
Acknowledgements 
The team would like to thank Mr. Rudy Krack, Mr. Mahmoud 
Moustafa, and Dr. Carl Wolf for their time and assistance with 
this project. 
 
References 
[1] Pitts SR, Niska RW, Xu J, Burt CW. National Hospital Ambulatory 
Medical Care Survey: 2006 emergency department summary. Natl 
Health Stat Report. 2008;7:1–38. 
[2] Farthing D, Xi L, Karnes HT, Sica D, Gehr T, Gehr L, Unverdorben 
M. “Method for diagnosing acute cardiac ischemia.” U.S. Patent 
8,343,731, 2013. 
[3] Lok, Khoi Seng, Yien Chian Kwok, and Nam-Trung Nguyen. "Double 
spiral detection channel for on-chip chemiluminescence detection." 
Sensors and Actuators B: Chemical 169 (2012): 144-50. 
Rapid, Diagnostic Test for Cardiac Ischemia 
 
CLSE 203  |  Team members: Jose Gonzales, Abdelmagid Nasreldeen, Emerson Physioc, Julio Contreras, and Evan Thoresen  | 
Faculty adviser: Dr. Nastassja Lewinski  |  Sponsor: VCU Anesthesiology/Nephrology  |  Sponsor adviser: Dr. Lynne Gehr and Dr. Todd Gehr 
   
Inosine 
Figure 2. Principle of the chemiluminescent ischemia bioassay. 
Figure 3. Top view diagram (left) and photo (right) of lab-on-chip design.  
Background 
Figure 1. Coronary events that can lead to ischemia. 
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Figure 4. Luminol reading from 12 well plate and lab-on-chip. 
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